trainer diseases

CHESTER, N. (ET).
Murray A.

inspiratory respiratory

(Nasdaq: ARXT) will provide a live audio webcast of a
management presentation at the Merrill Lynch Global Pharmaceutical,
Biotechnology and Medical Device Conference in New York City on Feb.

trainer tapes

J. A replay of the webcast will be
available later that day.

Business Editors/Health/Medical Writers
Deutsche Bank Securities Health Care Conference 2005
BIOWIRE2K

TARRYTOWN, N.

respiratory breathing

The session may be accessed through the
Company's website (www.

lungs resistive

9, 2006,
at approximately 8:00 a.Y. An archived
version of the presentation will be available after the live webcast
through June 1, 2005.

influenza tapes

breathing device

Additional information about Regeneron and recent news releases
are available on Regeneron's web site at www .

curing cold

Becker, executive vice president, CFO and Treasurer, will review the
company's most recent business and financial results. The
presentation is scheduled to be broadcast live on Tuesday, May 3, 2005
at 4:30 p.

homeopathic breathing

affect cure

(Nasdaq: REGN) will webcast its presentation at
the Deutsche Bank 30th Annual Health Care Conference on Tuesday, May
3, 2005.regeneron.

fee tapes

claims trainer

asthma cure

A live audio webcast of the presentation will be available by going to the
Investor Relations section of the Adams web site, http://www.

About Adams Respiratory Therapeutics, Inc.

device claims

Regeneron is a biopharmaceutical company that discovers , develops,
and intends to commercialize therapeutic medicines for the treatment
of serious medical conditions.

asthma claims

Valentino, president and CEO, and
David P.

Regeneron Announces Presentation at Deutsche Bank 30th Annual Health Care Conference

inspiratory resistive

com on the Events page, under the Investor
Relations heading ) at the time of the presentation.

common respiratory

Adams is a specialty pharmaceutical company focused on the late-stage
development, commercialization and marketing of over-the-counter and
prescription pharmaceuticals for the treatment of respiratory disorders.

influenza device

, Adams Respiratory
Therapeutics, Inc. Michael J.regn.com

claims homeopathic

claims respiratory

Goldberg, Senior Vice President, Finance and
Administration and Chief Financial Officer at Regeneron, will provide
an overview of the Company and its clinical candidates.

affect lungs

adamsrt .com, and
clicking on the "News and Events" link. Regeneron has therapeutic candidates
for the potential treatment of cancer, eye diseases, rheumatoid
arthritis and other inflammatory diseases , asthma and allergies and
has preclinical programs in other diseases and disorders.

common reduce

tapes breathing

Adams Respiratory Therapeutics to Webcast Management Presentation at Merrill Lynch Global Pharmaceutical Biotechnology and Medical Device Conference

----Regeneron
Pharmaceuticals, Inc. Eastern Time.